Edition:
India

Wockhardt Ltd (WCKH.NS)

WCKH.NS on National Stock Exchange of India

584.90INR
26 May 2017
Change (% chg)

Rs10.20 (+1.77%)
Prev Close
Rs574.70
Open
Rs579.80
Day's High
Rs594.90
Day's Low
Rs573.70
Volume
765,652
Avg. Vol
1,097,377
52-wk High
Rs1,129.05
52-wk Low
Rs557.55

WCKH.NS

Chart for WCKH.NS

About

Wockhardt Limited is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Aceroc, Alphadopa, Biovac Typhoid, Acetic Acid... (more)

Overall

Beta: 0.90
Market Cap(Mil.): Rs80,130.73
Shares Outstanding(Mil.): 110.55
Dividend: 10.00
Yield (%): 1.38

Financials

  WCKH.NS Industry Sector
P/E (TTM): -- 29.41 30.38
EPS (TTM): -2.64 -- --
ROI: -- 13.85 13.36
ROE: -- 14.79 14.50

MEDIA-India's Wockhardt looks for greener pastures as U.S. FDA issues linger -Business Standard

- Note: Reuters has not verified this story and does not vouch for its accuracy

09 May 2017

MEDIA-Wockhardt to make antibiotics, drugs for U.S. market at third-party facilities, Dubai plant - Business Standard

- Note: Reuters has not verified this story and does not vouch for its accuracy

18 Apr 2017

BRIEF-KPC Pharma to signs MOU with Swiss firm Wockhardt on sales of insulin related products in China

* Says it plans to signs MOU with Switzerland's Wockhardt on sales of insulin-related products in China

21 Mar 2017

MEDIA-India's Wockhardt Shendra plant yet to get Irish regulator's nod - Business Standard

- Note: Reuters has not verified this story and does not vouch for its accuracy

10 Mar 2017

BUZZ-India's Wockhardt falls after FDA issues warning letter to unit

** Shares of Wockhardt fall as much as 6.5 pct to 701 rupees in early trade

02 Mar 2017

More From Around the Web

Earnings vs. Estimates